New York- Presbyterian Hospital
New York-Presbyterian Hospital was formed in 1998 with the merger of New York Hospital and Presbyterian Hospital in New York City. New York-Presbyterian is the university hospital for Cornell and Columbia universities. New York-Presbyterian is actually five campuses. New York-Presbyterian Hospital/Columbia University Medical Center, New York-Presbyterian Hospital/Weill Cornell Medical Center, New-York Presbyterian Hospital/The Allen Pavilion, Morgan Stanley's Children's Hospital, New York-Presbyterian Hospital Westchester Division. New York-Presbyterian is rated as one of the largest medical centers in the world and is consistently rated in the top tier of teaching hospitals, research in complex diseases, cutting edge surgery and excellence in physician training.
Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Mass spectrometry helps researchers 'watch' how antibiotics attack tuberculosis bacteria inside cells
Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside ...
Medical research
Nov 01, 2012 |
not rated yet |
0
|
NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
Patients with hypertension whose blood pressure cannot be brought down to safe levels despite taking three or more medications may have some relief coming their way. An innovative, first-of-its-kind clinical trial for a device ...
Cardiology
Oct 25, 2012 |
not rated yet |
0
Electronic health records shown to improve the quality of patient care
A new study by Weill Cornell Medical College researchers, published in the Journal of General Internal Medicine, provides compelling evidence that electronic health records (EHRs) enhance the quality of patient care in a c ...
Health
Oct 09, 2012 |
not rated yet |
0
New definition of autism in DSM-5 will not exclude most children with autism, new study says
Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers ...
Autism spectrum disorders
Oct 02, 2012 |
4.8 / 5 (4) |
1
|
Learning to overcome fear is difficult for teens, brain study finds
A new study by Weill Cornell Medical College researchers shows that adolescents' reactions to threat remain high even when the danger is no longer present. According to researchers, once a teenager's brain is triggered by ...
Psychology & Psychiatry
Sep 27, 2012 |
4.2 / 5 (5) |
8
|
Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Cancer
Sep 17, 2012 |
not rated yet |
0
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Low cost pain drug can kill resistant tuberculosis
An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant ...
Diseases, Conditions, Syndromes
Sep 10, 2012 |
5 / 5 (5) |
4
|
Double drug combo could shut down abnormal blood vessel growth that feeds disease
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal—such as cancer, diabetic ...
Medical research
Sep 10, 2012 |
5 / 5 (2) |
0
|
Researchers show cost-effectiveness of HIV testing in drug abuse treatment programs
Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows ...
HIV & AIDS
Sep 09, 2012 |
not rated yet |
0
All grown up and gone for good? Advice on empty-nest syndrome
(Medical Xpress)—Your high school graduate is off to college to embark on a newly independent life. But they're not the only one making a transition: parents too face emotional and lifestyle adjustments. With advice on ...
Psychology & Psychiatry
Aug 30, 2012 |
not rated yet |
0
Doctors can now detect hard-to-diagnose prostate cancer
Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more ...
Cancer
Aug 09, 2012 |
5 / 5 (1) |
0
Researchers develop novel anti-body vaccine that blocks addictive nicotine chemicals from reaching the brain
Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.
Medical research
Jun 27, 2012 |
5 / 5 (7) |
7
|
Stopping and starting cancer cell cycle weakens and defeats multiple myeloma
Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then ...
Cancer
Jun 21, 2012 |
5 / 5 (1) |
0
|
